OPU
GRNA

Omni Partners US’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Omni Partners US’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$6.21M Buy
+628,312
New +$6.16M 0.32% 55

Other funds holding GRNA

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Omni Partners US's GRNA Position: Q3 2021 in Review

Omni Partners US opened a new position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2021: 628,312 shares worth $6.21M. The stake represents 0.32% of the portfolio and ranks #55 among its holdings.

70 funds tracked by Wall St. Rank hold GRNA as of Q3 2021.

  • Omni Partners US held 628,312 shares of GreenLight Biosciences Holdings, PBC Common Stock worth $6.21M as of Q3 2021.
  • GreenLight Biosciences Holdings, PBC Common Stock was a new Omni Partners US position in Q3 2021.
  • GreenLight Biosciences Holdings, PBC Common Stock made up 0.32% of Omni Partners US's portfolio in Q3 2021, its #55 holding.
  • 70 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2021.

Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.